OmniAb Historical Financial Ratios
| OABI Stock | USD 2.42 0.05 2.02% |
OmniAb is promptly reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 69.27 will help investors to properly organize and evaluate OmniAb Inc financial condition quickly.
OmniAb |
About OmniAb Financial Ratios Analysis
OmniAb IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OmniAb investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OmniAb financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OmniAb history.
OmniAb Financial Ratios Chart
Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from OmniAb's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OmniAb Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of now, OmniAb's Income Quality is decreasing as compared to previous years. The OmniAb's current Intangibles To Total Assets is estimated to increase to 0.85, while Price To Sales Ratio is projected to decrease to 13.04.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 187.14 | 41.07 | 72.91 | 69.27 | PTB Ratio | 0.9 | 1.96 | 1.26 | 1.2 |
OmniAb fundamentals Correlations
Click cells to compare fundamentals
OmniAb Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OmniAb fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 48.16 | 23.77 | 5.2 | 18.0 | 13.73 | 13.04 | |
| Ptb Ratio | 4.76 | 3.53 | 0.9 | 1.96 | 1.26 | 1.2 | |
| Days Sales Outstanding | 249.03 | 222.02 | 187.14 | 41.07 | 72.91 | 69.27 | |
| Book Value Per Share | 2.05 | 2.84 | 4.0 | 3.16 | 2.81 | 2.23 | |
| Operating Cash Flow Per Share | 0.0315 | (0.0687) | (0.042) | 0.0235 | (0.39) | (0.37) | |
| Stock Based Compensation To Revenue | 0.39 | 0.43 | 0.31 | 0.73 | 0.81 | 0.41 | |
| Capex To Depreciation | 0.13 | 0.25 | 0.94 | 0.0843 | 0.0795 | 0.0755 | |
| Pb Ratio | 4.76 | 3.53 | 0.9 | 1.96 | 1.26 | 1.2 | |
| Ev To Sales | 48.39 | 24.57 | 5.07 | 18.27 | 13.56 | 12.88 | |
| Free Cash Flow Per Share | 0.0163 | (0.12) | (0.24) | 0.007052 | (0.41) | (0.39) | |
| Roic | (0.0672) | (0.0985) | (0.0573) | (0.15) | (0.21) | (0.22) | |
| Net Income Per Share | (0.15) | (0.33) | (0.26) | (0.51) | (0.61) | (0.64) | |
| Sales General And Administrative To Revenue | 0.44 | 0.49 | 0.42 | 0.98 | 1.16 | 1.22 | |
| Research And Ddevelopement To Revenue | 1.07 | 1.13 | 0.82 | 1.65 | 2.09 | 2.19 | |
| Capex To Revenue | 0.0753 | 0.12 | 0.29 | 0.0481 | 0.071 | 0.08 | |
| Pocfratio | 309.66 | (145.65) | (85.63) | 262.06 | (9.14) | (8.68) | |
| Capex To Operating Cash Flow | 0.48 | (0.72) | (4.79) | 0.7 | (0.0473) | (0.0496) | |
| Pfcf Ratio | 600.56 | (84.8) | (14.8) | 874.88 | (8.72) | (8.29) | |
| Income Quality | (0.21) | 0.21 | 0.16 | (0.0464) | 0.64 | 0.67 | |
| Roe | (0.0745) | (0.12) | (0.0654) | (0.16) | (0.22) | (0.23) | |
| Ev To Operating Cash Flow | 311.09 | (150.53) | (83.51) | 265.98 | (9.02) | (8.57) | |
| Pe Ratio | (63.83) | (30.55) | (13.75) | (12.15) | (5.84) | (6.13) | |
| Return On Tangible Assets | (0.71) | (0.61) | (0.13) | (0.37) | (0.6) | (0.63) | |
| Ev To Free Cash Flow | 603.34 | (87.64) | (14.43) | 887.98 | (8.62) | (8.19) | |
| Earnings Yield | (0.0157) | (0.0327) | (0.0727) | (0.0823) | (0.17) | (0.16) | |
| Net Debt To E B I T D A | (0.49) | (1.43) | 0.58 | (0.19) | 0.0595 | 0.0625 | |
| Current Ratio | 1.17 | 1.1 | 4.8 | 4.11 | 4.52 | 2.26 | |
| Receivables Turnover | 1.47 | 1.64 | 1.95 | 8.89 | 5.01 | 2.84 | |
| Shareholders Equity Per Share | 2.05 | 2.84 | 4.0 | 3.16 | 2.81 | 2.23 | |
| Debt To Equity | 0.011 | 0.0591 | 0.0756 | 0.0813 | 0.0805 | 0.0424 | |
| Capex Per Share | 0.0153 | 0.0493 | 0.2 | 0.0165 | 0.0183 | 0.0174 | |
| Graham Net Net | (0.43) | (0.74) | 0.37 | 0.29 | 0.25 | 0.26 | |
| Revenue Per Share | 0.2 | 0.42 | 0.69 | 0.34 | 0.26 | 0.28 | |
| Interest Debt Per Share | 0.0226 | 0.17 | 0.3 | 0.26 | 0.23 | 0.14 | |
| Debt To Assets | 0.008775 | 0.0455 | 0.0612 | 0.0681 | 0.0712 | 0.0747 | |
| Enterprise Value Over E B I T D A | (106.35) | (44.07) | (23.02) | (12.55) | (4.8) | (5.04) |
Currently Active Assets on Macroaxis
When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 1.241 | Return On Assets | Return On Equity |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.